By Josh Beckerman An Intercept Pharmaceuticals Inc. drug received two unfavorable votes from a Food and Drug Administration advisory committee. Intercept shares were halted...
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you weekly! INVESTING...